Perspectives
Patient Schematics
For many physicians, their patients come to symbolize many things. For this particular physician, the patients appear as different symbols...
Read more
Gaming Therapy
DEA Agents Martin and Jennings find themselves in the middle of another physician investigation, analyzing data to determine what they...
Read more
There Is A Doctor On The Ballot
To celebrate Election Day, Daily Remedy unveils a short story about a physician entering the world of politics. Dr. Kapoor,...
Read more
A Patient Named Candide
A satirical tale inspired by the novella, Candide by the French philosopher Voltaire, reimagines Candide as a patient in today's...
Read more
The BOP In The Age of Corona
A gritty tale of life inside a federal prison as inmates face and attempt to understand COVID-19 risks.
Read more
A Moment of Duality
A medical short story inspired by the late, great WEB DuBois.
Read more
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more